{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:21:04Z","timestamp":1780392064369,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Peking University International Hospital Research Fund","award":["No. YN2021ZD04"],"award-info":[{"award-number":["No. YN2021ZD04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-17128-5","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:33:34Z","timestamp":1756481614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The association of the systemic inflammation response index with the prognosis of primary retroperitoneal liposarcoma after surgical resection"],"prefix":"10.1038","volume":"15","author":[{"given":"Weida","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengli","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"17128_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1200\/jco.2017.74.9598","volume":"2","author":"ATJ Lee","year":"2018","unstructured":"Lee, A. T. J., Thway, K., Huang, P. H. & Jones, R. L. Clinical and molecular spectrum of liposarcoma. J. Clin. Oncol. 2, 151\u2013159. https:\/\/doi.org\/10.1200\/jco.2017.74.9598 (2018).","journal-title":"J. Clin. Oncol."},{"key":"17128_CR2","doi-asserted-by":"publisher","unstructured":"Singer, S., Antonescu, C. R., Riedel, E. & Brennan, M. F. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann. Surg. 3 https:\/\/doi.org\/10.1097\/01.sla.0000086542.11899.38 (2003). 358\u2009\u2013\u200970; discussion 70\u2009\u2013\u20091.","DOI":"10.1097\/01.sla.0000086542.11899.38"},{"key":"17128_CR3","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pathol.1.110304.100052","author":"M Van De Rijn","year":"2006","unstructured":"Van De Rijn, M. & Fletcher, J. A. Genetics of soft tissue tumors. Annu. Rev. Pathol. https:\/\/doi.org\/10.1146\/annurev.pathol.1.110304.100052 (2006). 435\u2009\u2013\u200966.","journal-title":"Annu. Rev. Pathol."},{"key":"17128_CR4","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1002\/ijc.23380","volume":"10","author":"A Italiano","year":"2008","unstructured":"Italiano, A. et al. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Int. J. Cancer. 10, 2233\u20132241. https:\/\/doi.org\/10.1002\/ijc.23380 (2008).","journal-title":"Int. J. Cancer"},{"key":"17128_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-77960-5_19","author":"MH Schwarzbach","year":"2009","unstructured":"Schwarzbach, M. H. & Hohenberger, P. Current concepts in the management of retroperitoneal soft tissue sarcoma. Recent. Results Cancer Res. 301 \u2013 19. https:\/\/doi.org\/10.1007\/978-3-540-77960-5_19 (2009).","journal-title":"Recent. Results Cancer Res. 301 \u2013 19"},{"key":"17128_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1001\/archsurg.138.3.248","volume":"3","author":"T Ferrario","year":"2003","unstructured":"Ferrario, T. & Karakousis, C. P. Retroperitoneal sarcomas: grade and survival. Arch. Surg. 3, 248\u2013251. https:\/\/doi.org\/10.1001\/archsurg.138.3.248 (2003).","journal-title":"Arch. Surg."},{"key":"17128_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/jso.20543","volume":"1","author":"CP Raut","year":"2006","unstructured":"Raut, C. P. & Pisters, P. W. Retroperitoneal sarcomas: Combined-modality treatment approaches. J. Surg. Oncol. 1, 81\u201387. https:\/\/doi.org\/10.1002\/jso.20543 (2006).","journal-title":"J. Surg. Oncol."},{"key":"17128_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/SLA.0b013e3181928f2f","volume":"1","author":"DA Anaya","year":"2009","unstructured":"Anaya, D. A. et al. Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making. Ann. Surg. 1, 137\u2013142. https:\/\/doi.org\/10.1097\/SLA.0b013e3181928f2f (2009).","journal-title":"Ann. Surg."},{"key":"17128_CR9","doi-asserted-by":"publisher","first-page":"300060521106308","DOI":"10.1177\/03000605211063085","volume":"12","author":"S Wang","year":"2021","unstructured":"Wang, S., Han, X., Liu, S., Xu, G. & Li, J. Primary retroperitoneal liposarcoma: a rare case report. J. Int. Med. Res. 12, 3000605211063085. https:\/\/doi.org\/10.1177\/03000605211063085 (2021).","journal-title":"J. Int. Med. Res."},{"key":"17128_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/s0301-2115(02)00484-0","author":"MA Osmana\u011fao\u011flu","year":"2003","unstructured":"Osmana\u011fao\u011flu, M. A., Bozkaya, H., Ozeren, M. & Cobano\u011flu, U. Primary retroperitoneal liposarcoma. Eur. J. Obstet. Gynecol. Reprod. Biol. https:\/\/doi.org\/10.1016\/s0301-2115(02)00484-0 (2003). 2: 228\u2009\u2013\u200930.","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"17128_CR11","doi-asserted-by":"publisher","unstructured":"Chen, Y., Jin, M., Shao, Y. & Xu, G. Prognostic value of the systemic inflammation response index in patients with adenocarcinoma of the oesophagogastric junction: A propensity Score-Matched analysis. Dis. Markers. 4659048. https:\/\/doi.org\/10.1155\/2019\/4659048 (2019).","DOI":"10.1155\/2019\/4659048"},{"key":"17128_CR12","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/cncr.30057","volume":"14","author":"Q Qi","year":"2016","unstructured":"Qi, Q. et al. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer 14, 2158\u20132167. https:\/\/doi.org\/10.1002\/cncr.30057 (2016).","journal-title":"Cancer"},{"key":"17128_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41419-023-05602-9","volume":"1","author":"Y Cao","year":"2023","unstructured":"Cao, Y. et al. Levels of systemic inflammation response index are correlated with tumor-associated bacteria in colorectal cancer. Cell. Death Dis. 1, 69. https:\/\/doi.org\/10.1038\/s41419-023-05602-9 (2023).","journal-title":"Cell. Death Dis."},{"key":"17128_CR14","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/jcsm.13032","volume":"5","author":"M Song","year":"2022","unstructured":"Song, M. et al. The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer. J. Cachexia Sarcopenia Muscle. 5, 2504\u20132514. https:\/\/doi.org\/10.1002\/jcsm.13032 (2022).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"17128_CR15","doi-asserted-by":"publisher","unstructured":"Zhu, M. et al. The systemic inflammation response index as an independent predictor of survival in breast cancer patients: A retrospective study. Front. Mol. Biosci. 856064. https:\/\/doi.org\/10.3389\/fmolb.2022.856064 (2022).","DOI":"10.3389\/fmolb.2022.856064"},{"key":"17128_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12893-024-02384-5","volume":"1","author":"Y Ding","year":"2024","unstructured":"Ding, Y. et al. Predictive effect of the systemic inflammation response index (SIRI) on the efficacy and prognosis of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer. BMC Surg. 1, 89. https:\/\/doi.org\/10.1186\/s12893-024-02384-5 (2024).","journal-title":"BMC Surg."},{"key":"17128_CR17","doi-asserted-by":"publisher","unstructured":"Zhao, M. et al. Sarcopenia and systemic inflammation response index predict response to systemic therapy for hepatocellular carcinoma and are associated with immune cells. Front. Oncol. 854096. https:\/\/doi.org\/10.3389\/fonc.2022.854096 (2022).","DOI":"10.3389\/fonc.2022.854096"},{"key":"17128_CR18","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/ijc.34547","volume":"4","author":"P Wang","year":"2023","unstructured":"Wang, P. et al. Systemic inflammation influences the prognosis of patients with radically resected non-small cell lung cancer and correlates with the immunosuppressive microenvironment. Int. J. Cancer. 4, 826\u2013842. https:\/\/doi.org\/10.1002\/ijc.34547 (2023).","journal-title":"Int. J. Cancer"},{"key":"17128_CR19","doi-asserted-by":"publisher","DOI":"10.2147\/jir.S501079","author":"Y Yan","year":"2025","unstructured":"Yan, Y. et al. Prognostic value of inflammatory and nutritional indicators in Non-Metastatic soft tissue sarcomas. J. Inflamm. Res. https:\/\/doi.org\/10.2147\/jir.S501079 (2025)., 1941-50.","journal-title":"J. Inflamm. Res."},{"key":"17128_CR20","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.21873\/anticanres.17018","volume":"5","author":"T Imai","year":"2024","unstructured":"Imai, T. et al. Predicting trabectedin efficacy in soft tissue sarcoma: inflammatory biomarker analysis. Anticancer Res. 5, 2125\u20132132. https:\/\/doi.org\/10.21873\/anticanres.17018 (2024).","journal-title":"Anticancer Res."},{"key":"17128_CR21","doi-asserted-by":"publisher","unstructured":"Tuzimek, A., Dziedzic, E. A., Beck, J. & Kochman, W. Correlations between acute coronary syndrome and novel inflammatory markers (Systemic Immune-Inflammation index, systemic inflammation response index, and aggregate index of systemic inflammation) in patients with and without diabetes or prediabetes. J. Inflamm. Res. 2623\u20132632. https:\/\/doi.org\/10.2147\/jir.S454117 (2024).","DOI":"10.2147\/jir.S454117"},{"key":"17128_CR22","doi-asserted-by":"publisher","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","volume":"6","author":"AJ Templeton","year":"2014","unstructured":"Templeton, A. J. et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J. Natl. Cancer Inst. 6, dju124. https:\/\/doi.org\/10.1093\/jnci\/dju124 (2014).","journal-title":"J. Natl. Cancer Inst."},{"key":"17128_CR23","doi-asserted-by":"publisher","first-page":"e22964","DOI":"10.1002\/jcla.22964","volume":"8","author":"J Liu","year":"2019","unstructured":"Liu, J. et al. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. J. Clin. Lab. Anal. 8, e22964. https:\/\/doi.org\/10.1002\/jcla.22964 (2019).","journal-title":"J. Clin. Lab. Anal."},{"key":"17128_CR24","doi-asserted-by":"publisher","first-page":"8937","DOI":"10.3390\/curroncol29110702","volume":"11","author":"X Ma","year":"2022","unstructured":"Ma, X. et al. Nomogram based on Monocyte-to-Lymphocyte ratio to predict survival of unresectable esophageal squamous cell carcinoma who receive First-Line PD-1\/PD-L1 inhibitors combined with chemotherapy. Curr. Oncol. 11, 8937\u20138954. https:\/\/doi.org\/10.3390\/curroncol29110702 (2022).","journal-title":"Curr. Oncol."},{"key":"17128_CR25","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1182\/blood-2018-11-844548","volume":"20","author":"MA Giese","year":"2019","unstructured":"Giese, M. A., Hind, L. E. & Huttenlocher, A. Neutrophil plasticity in the tumor microenvironment. Blood 20, 2159\u20132167. https:\/\/doi.org\/10.1182\/blood-2018-11-844548 (2019).","journal-title":"Blood"},{"key":"17128_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","volume":"3","author":"ZG Fridlender","year":"2009","unstructured":"Fridlender, Z. G. et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: N1 versus N2 TAN. Cancer Cell. 3, 183\u2013194. https:\/\/doi.org\/10.1016\/j.ccr.2009.06.017 (2009).","journal-title":"Cancer Cell."},{"key":"17128_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ccr.2009.08.014","volume":"3","author":"A Mantovani","year":"2009","unstructured":"Mantovani, A. The yin-yang of tumor-associated neutrophils. Cancer Cell. 3, 173\u2013174. https:\/\/doi.org\/10.1016\/j.ccr.2009.08.014 (2009).","journal-title":"Cancer Cell."},{"key":"17128_CR28","doi-asserted-by":"publisher","unstructured":"Ribatti, D. A double-edged sword in tumor angiogenesis and progression. Dual roles of mast cells, macrophages, and neutrophils. Pathol. Res. Pract. 154167. https:\/\/doi.org\/10.1016\/j.prp.2022.154167 (2022).","DOI":"10.1016\/j.prp.2022.154167"},{"key":"17128_CR29","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41419-022-04821-w","volume":"4","author":"L Zhao","year":"2022","unstructured":"Zhao, L. et al. Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer. Cell. Death Dis. 4, 378. https:\/\/doi.org\/10.1038\/s41419-022-04821-w (2022).","journal-title":"Cell. Death Dis."},{"key":"17128_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10585-018-9874-1","volume":"1\u20132","author":"AJ Gareau","year":"2018","unstructured":"Gareau, A. J. et al. Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer. Clin. Exp. Metastasis. 1\u20132, 25\u201335. https:\/\/doi.org\/10.1007\/s10585-018-9874-1 (2018).","journal-title":"Clin. Exp. Metastasis"},{"key":"17128_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13045-018-0669-2","volume":"1","author":"M Schlesinger","year":"2018","unstructured":"Schlesinger, M. Role of platelets and platelet receptors in cancer metastasis. J. Hematol. Oncol. 1, 125. https:\/\/doi.org\/10.1186\/s13045-018-0669-2 (2018).","journal-title":"J. Hematol. Oncol."},{"key":"17128_CR32","doi-asserted-by":"publisher","unstructured":"Lu, M. et al. Platelets promote primary hepatocellular carcinoma metastasis through TGF-\u03b21-mediated cancer cell autophagy. Cancer Lett. 217161. https:\/\/doi.org\/10.1016\/j.canlet.2024.217161 (2024).","DOI":"10.1016\/j.canlet.2024.217161"},{"key":"17128_CR33","first-page":"3577","volume":"7","author":"S Pan","year":"2020","unstructured":"Pan, S. et al. Platelet-derived PDGF promotes the invasion and metastasis of cholangiocarcinoma by upregulating MMP2\/MMP9 expression and inducing EMT via the p38\/MAPK signalling pathway. Am. J. Transl Res. 7, 3577\u20133595 (2020).","journal-title":"Am. J. Transl Res."},{"key":"17128_CR34","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1039\/d0na00271b","volume":"9","author":"N Ortiz-Otero","year":"2020","unstructured":"Ortiz-Otero, N., Marshall, J. R., Lash, B. W. & King, M. R. Platelet mediated TRAIL delivery for efficiently targeting Circulating tumor cells. Nanoscale Adv. 9, 3942\u20133953. https:\/\/doi.org\/10.1039\/d0na00271b (2020).","journal-title":"Nanoscale Adv."},{"key":"17128_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"1","author":"BZ Qian","year":"2010","unstructured":"Qian, B. Z. & Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell 1, 39\u201351. https:\/\/doi.org\/10.1016\/j.cell.2010.03.014 (2010).","journal-title":"Cell"},{"key":"17128_CR36","doi-asserted-by":"publisher","unstructured":"Boutilier, A. J. & Elsawa, S. F. Macrophage polarization States in the tumor microenvironment. Int. J. Mol. Sci. 13 https:\/\/doi.org\/10.3390\/ijms22136995 (2021).","DOI":"10.3390\/ijms22136995"},{"key":"17128_CR37","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/s1471-4906(02)02302-5","volume":"11","author":"A Mantovani","year":"2002","unstructured":"Mantovani, A., Sozzani, S., Locati, M., Allavena, P. & Sica, A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 11, 549\u2013555. https:\/\/doi.org\/10.1016\/s1471-4906(02)02302-5 (2002).","journal-title":"Trends Immunol."},{"key":"17128_CR38","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1161\/atvbaha.113.300168","volume":"7","author":"A Mantovani","year":"2013","unstructured":"Mantovani, A. & Locati, M. Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions. Arterioscler. Thromb. Vasc Biol. 7, 1478\u20131483. https:\/\/doi.org\/10.1161\/atvbaha.113.300168 (2013).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"17128_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13046-023-02742-w","volume":"1","author":"Y Xu","year":"2023","unstructured":"Xu, Y. et al. TRAF2 promotes M2-polarized tumor-associated macrophage infiltration, angiogenesis and cancer progression by inhibiting autophagy in clear cell renal cell carcinoma. J. Exp. Clin. Cancer Res. 1, 159. https:\/\/doi.org\/10.1186\/s13046-023-02742-w (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"17128_CR40","doi-asserted-by":"publisher","unstructured":"Basak, U. et al. Tumor-associated macrophages: an effective player of the tumor microenvironment. Front. Immunol. 1295257. https:\/\/doi.org\/10.3389\/fimmu.2023.1295257 (2023).","DOI":"10.3389\/fimmu.2023.1295257"},{"key":"17128_CR41","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1515\/hsz-2021-0209","volume":"9","author":"C Ehlting","year":"2021","unstructured":"Ehlting, C., Wolf, S. D. & Bode, J. G. Acute-phase protein synthesis: a key feature of innate immune functions of the liver. Biol. Chem. 9, 1129\u20131145. https:\/\/doi.org\/10.1515\/hsz-2021-0209 (2021).","journal-title":"Biol. Chem."},{"key":"17128_CR42","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/cmi.2016.3","volume":"3","author":"MW Robinson","year":"2016","unstructured":"Robinson, M. W., Harmon, C. & O\u2019farrelly, C. Liver immunology and its role in inflammation and homeostasis. Cell. Mol. Immunol. 3, 267\u2013276. https:\/\/doi.org\/10.1038\/cmi.2016.3 (2016).","journal-title":"Cell. Mol. Immunol."},{"key":"17128_CR43","doi-asserted-by":"publisher","unstructured":"Errani, C. et al. The Prognostic Value of the Serum Level of C-Reactive Protein for Survival of Children with Ewing\u2019s Sarcoma. Cancers (Basel). 5 https:\/\/doi.org\/10.3390\/cancers15051573 (2023).","DOI":"10.3390\/cancers15051573"},{"key":"17128_CR44","doi-asserted-by":"publisher","first-page":"e0219215","DOI":"10.1371\/journal.pone.0219215","volume":"7","author":"X Wang","year":"2019","unstructured":"Wang, X., Liu, S., Zhao, X., Fang, E. & Zhao, X. The value of C-reactive protein as an independent prognostic indicator for disease-specific survival in patients with soft tissue sarcoma: A meta-analysis. PLoS One. 7, e0219215. https:\/\/doi.org\/10.1371\/journal.pone.0219215 (2019).","journal-title":"PLoS One"},{"key":"17128_CR45","doi-asserted-by":"publisher","unstructured":"Menon, S. S., Guruvayoorappan, C., Sakthivel, K. M. & Rasmi, R. R. Ki-67 protein as a tumour proliferation marker. Clin. Chim. Acta. 39\u201345. https:\/\/doi.org\/10.1016\/j.cca.2019.01.011 (2019).","DOI":"10.1016\/j.cca.2019.01.011"},{"key":"17128_CR46","doi-asserted-by":"publisher","unstructured":"Somaiah, N. & Tap, W. MDM2-p53 in liposarcoma: the need for targeted therapies with novel mechanisms of action. Cancer Treat. Rev. 102668. https:\/\/doi.org\/10.1016\/j.ctrv.2023.102668 (2024).","DOI":"10.1016\/j.ctrv.2023.102668"},{"key":"17128_CR47","doi-asserted-by":"publisher","first-page":"101790","DOI":"10.1016\/j.jsps.2023.101790","volume":"10","author":"AM Alaseem","year":"2023","unstructured":"Alaseem, A. M. Advancements in MDM2 inhibition: clinical and pre-clinical investigations of combination therapeutic regimens. Saudi Pharm. J. 10, 101790. https:\/\/doi.org\/10.1016\/j.jsps.2023.101790 (2023).","journal-title":"Saudi Pharm. J."},{"key":"17128_CR48","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00262-020-02511-0","volume":"5","author":"L Zhou","year":"2020","unstructured":"Zhou, L. et al. LincRNA-p21 knockdown reversed tumor-associated macrophages function by promoting MDM2 to antagonize* p53 activation and alleviate breast cancer development. Cancer Immunol. Immunother. 5, 835\u2013846. https:\/\/doi.org\/10.1007\/s00262-020-02511-0 (2020).","journal-title":"Cancer Immunol. Immunother"},{"key":"17128_CR49","doi-asserted-by":"publisher","unstructured":"Li, Y. et al. Tumor microenvironment promotes lymphatic metastasis of cervical cancer: its mechanisms and clinical implications. Front. Oncol. 1114042. https:\/\/doi.org\/10.3389\/fonc.2023.1114042 (2023).","DOI":"10.3389\/fonc.2023.1114042"},{"key":"17128_CR50","doi-asserted-by":"publisher","unstructured":"Ozel, I. et al. The good, the bad, and the ugly: neutrophils, angiogenesis, and cancer. Cancers (Basel). 3 https:\/\/doi.org\/10.3390\/cancers14030536 (2022).","DOI":"10.3390\/cancers14030536"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17128-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17128-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17128-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:33:35Z","timestamp":1756481615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17128-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17128"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17128-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"8 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Peking University International Hospital. Written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"31884"}}